CAAS Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,121	Closed	-$498K	–	497
2021 Q4	$498K	Buy	+7,121	New	+$498K	0.01%	223